Login / Signup

Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation.

Tobias RheudeCostanza PellegriniWibke ReinhardTeresa TrenkwalderWolfgang KoenigNicola Patrick MayrMichael JonerJulio NúñezStefan HoldenriederHeribert SchunkertAdnan KastratiChristian HengstenbergOliver Husser
Published in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2018)
Elevated CA125 levels in patients referred for TAVI summarize a subset of patients with an overall worse clinical profile who are more symptomatic.
Keyphrases
  • transcatheter aortic valve implantation
  • aortic valve
  • aortic valve replacement
  • aortic stenosis
  • transcatheter aortic valve replacement
  • early onset
  • heart failure
  • coronary artery disease
  • drug induced